Adma Biologics Inc (ADMA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Adma Biologics Inc-Aktie (ADMA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	10.79% 81.88	73.90	67.27	60.12	56.91
Cost Of Revenue	0.12% 42.77	42.82	42.62	43.43	40.40
Gross Profit	25.80% 39.11	31.09	24.65	16.69	16.51
Operating Expenses	2.57% 17.29	16.85	15.97	17.16	17.33
Interest Income/Expense	39.35% 3.769	6.2149	6.3976	6.2991	6.1155
Benefits Costs and Expenses	63.47	-	-	-	-
Costs And Expenses	6.37% 63.47	59.67	58.59	60.60	57.73
Depreciation and Amortization	0.24% 2.114	2.109	2.0925	2.0976	2.033
Operating Income/Loss	53.31% 21.82	14.23	8.6852	-0.4731	-0.8133
Nonoperating Income/Loss	89.27% -3.42	-31.88	-6.1201	-5.8976	-5.9755
Income/Loss From Continuing Operations Before Tax	75.10% 18.40	73.90	67.27	-6.3707	-6.7888
Income Tax Expense/Benefit	0.595	-	-	-	-
Income/Loss From Continuing Operations After Tax	200.92% 17.81	-17.64	2.5651	-6.3707	-6.7888
Net Income/Loss	200.92% 17.81	-17.64	2.5651	-6.3707	-6.7888
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	34,010% 228.87	0.671	225.28	222.68	221.92
Diluted Average Shares	35,134% 236.41	0.671	233.76	222.68	221.92
Basic Earnings Per Share	200.00% 0.08	-0.08	0.01	-0.03	-0.03
Diluted Earnings Per Share	200.00% 0.08	-0.08	0.01	-0.03	-0.03
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.98

3.66%

INCY

$76.97

1.45%

MRNA

$39.51

7.22%

UTHR

$359.21

1.11%

BGNE

$187.69

0.81%

BNTX

$101.87

2.16%